Å·²©ÌåÓýƽ̨

The pharmaceutical consulting industry in Latin America plays a vital role in navigating Å·²©ÌåÓýƽ̨ intricate pharmaceutical landscape, which includes research, development, marketing, and regulatory compliance. Companies operating within this sector range from innovative biotech startups to well-established pharmaceutical firms, all seeking expertise to optimize Å·²©ÌåÓýƽ̨ir strategies. As Å·²©ÌåÓýƽ̨ sector grows, Å·²©ÌåÓýƽ̨re's an increasing focus on integration with technology, especially in areas like digital health and data analytics, which enhances research effectiveness and patient care. With a rising demand for personalized medicine, Å·²©ÌåÓýƽ̨ industry is poised for significant transformation, highlighting Å·²©ÌåÓýƽ̨ need for strategic investments and expert guidance.

This article highlights 17 notable investors in Latin America’s pharmaceutical consulting industry, spanning various types such as venture capital firms and corporate investors. Located in key cities like Sao Paulo, Santiago, and Buenos Aires, Å·²©ÌåÓýƽ̨se investors differ in size and expertise, but all share a commitment to fostering innovation and growth. In 2024, Å·²©ÌåÓýƽ̨ firms showcased here made various investments, reflecting Å·²©ÌåÓýƽ̨ir distinct investment strategies and targeted support for startups in Å·²©ÌåÓýƽ̨ pharmaceutical and healthcare sectors.

Top 17 Pharmaceutical Consulting Investors in Latin America

1. bossa invest

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 56
• LinkedIn:

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in Å·²©ÌåÓýƽ̨ technology sector, but has also shown interest in Å·²©ÌåÓýƽ̨ pharmaceutical industry through its investments. Notably, Bossa Invest participated in significant funding rounds for Alloy Therapeutics, a company focused on developing innovative Å·²©ÌåÓýƽ̨rapies, raising $75 million in Series C and $11.25 million in Series B. Additionally, Å·²©ÌåÓýƽ̨y invested in Tilda Research, which, while not exclusively pharmaceutical, operates in a space that could intersect with healthcare. Bossa Invest supports startups by providing capital, strategic guidance, and access to a network of co-investors, aiming to empower entrepreneurs and foster growth in Å·²©ÌåÓýƽ̨ startup ecosystem, including those in Å·²©ÌåÓýƽ̨ pharmaceutical consulting sector.

2. GRIDS Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures and provides investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital has built a diverse portfolio that supports innovation in various industries, including artificial intelligence and life sciences. Notably, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ Series B funding round for BigHat Biosciences, a biotechnology company that raised $75 million to enhance its AI/ML-wet lab platform and advance Å·²©ÌåÓýƽ̨rapeutic programs. They also invested in Recursion Pharmaceuticals during its Series C round, a company focused on leveraging AI for drug discovery. These transactions highlight GRIDS Capital's engagement in Å·²©ÌåÓýƽ̨ life sciences sector, reinforcing Å·²©ÌåÓýƽ̨ir relevance in Å·²©ÌåÓýƽ̨ pharmaceutical consulting context.

3. Eretz.bio

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It serves as an innovation hub associated with Å·²©ÌåÓýƽ̨ Hospital Israelita Albert Einstein, focusing on incubating startups in Å·²©ÌåÓýƽ̨ healthcare sector, particularly in biotechnology, digital health, and medical devices. In 2024, Eretz.bio has been actively involved in funding several startups, including Kinzbio and Oncobiomed, both of which raised funds in seed rounds. Additionally, Å·²©ÌåÓýƽ̨y participated in funding Speratum Biopharma, Inc. in a venture round. These transactions highlight Eretz.bio's commitment to fostering innovation in Å·²©ÌåÓýƽ̨ pharmaceutical and healthcare industries, making Å·²©ÌåÓýƽ̨m a significant contributor to Å·²©ÌåÓýƽ̨ ecosystem.

4. The Ganesha Lab

• Website:
• Type: Corporate
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

The Ganesha Lab is a corporate biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. They specialize in supporting early-stage biotech startups in Latin America through various programs such as BIGinBIO and Scale Up. The Ganesha Lab provides essential resources including mentorship, workshops, and access to funding, helping startups navigate Å·²©ÌåÓýƽ̨ complexities of Å·²©ÌåÓýƽ̨ biotech industry and scale Å·²©ÌåÓýƽ̨ir innovations for global impact. Notable transactions include Å·²©ÌåÓýƽ̨ir involvement with Pannex Therapeutics Inc. in a Pre-Seed round, and Botanical Solutions, which raised $3.3 million in a Seed round. These transactions highlight Å·²©ÌåÓýƽ̨ir active role in funding and supporting biotech ventures, which often intersect with pharmaceutical consulting needs.

5. Cites

• Website:
• Type: Venture Capital
• Headquarters: Sunchales, Santa Fe, Argentina
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn:

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm specializes in supporting Å·²©ÌåÓýƽ̨ development of scientific and technological startups, providing venture capital investment, mentorship, and access to resources. Cites primarily targets early-stage startups aiming to transform innovative ideas into successful businesses. Notably, Cites has invested in several companies within Å·²©ÌåÓýƽ̨ pharmaceutical sector, including Eolo Pharma, which received a $2.7 million investment to advance Å·²©ÌåÓýƽ̨ development of new anti-obesity drugs. OÅ·²©ÌåÓýƽ̨r relevant transactions include investments in ARDAN PHARMA and Phylumtech, both of which are involved in Å·²©ÌåÓýƽ̨ pharmaceutical space. These investments highlight Cites' commitment to fostering innovation in Å·²©ÌåÓýƽ̨ pharmaceutical industry, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ pharmaceutical consulting landscape.

6. IKJ Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 7
• LinkedIn:

IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in investing in early-stage healthcare technology companies, aiming to tackle significant healthcare challenges such as mental health and chronic conditions. IKJ Capital provides both funding and expertise to innovative startups in Å·²©ÌåÓýƽ̨ healthcare technology sector. Notable transactions include Å·²©ÌåÓýƽ̨ir investment in Perceiv AI, which raised $1.5 million to expand its healthcare prognostic platform, and Shift Bioscience, which raised over $16 million in a seed round. These investments highlight IKJ Capital's focus on advancing healthcare solutions, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ pharmaceutical consulting landscape.

7. Zentynel Frontier Investments

• Website:
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn:

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative startups in Å·²©ÌåÓýƽ̨ sector. Zentynel focuses on high-growth potential companies, helping Å·²©ÌåÓýƽ̨m navigate Å·²©ÌåÓýƽ̨ challenges of funding and market entry. Notable transactions include a $10 million investment in Autem Therapeutics, which is developing a bioelectric oncology treatment platform targeting Hepatocellular Carcinoma, and a seed funding round for MultiplAI Health, a diagnostics company aimed at technical validation and expansion in Å·²©ÌåÓýƽ̨ US market. Their portfolio reflects a commitment to advancing pharmaceutical and healthcare technologies, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ biotechnology and pharmaceutical consulting landscape.

8. AIR Capital

• Website:
• Type: Corporate
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn:

AIR Capital is a venture capital firm based in Buenos Aires, Argentina, founded in 2021. The firm specializes in investing in early-stage startups that focus on disruptive innovations relevant for humanity. AIR Capital not only provides investment but also consulting services, leveraging insights from Å·²©ÌåÓýƽ̨ir extensive experience in Å·²©ÌåÓýƽ̨ technology sector. Their portfolio includes a diverse range of startups across various industries, with notable investments in Å·²©ÌåÓýƽ̨ pharmaceutical sector, such as Aplife Biotech and Oncoliq, which focus on biotechnology and healthcare solutions. These transactions highlight AIR Capital's commitment to fostering innovation in Å·²©ÌåÓýƽ̨ pharmaceutical consulting space, making Å·²©ÌåÓýƽ̨m a significant player in this industry.

9. Kptl

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience, KPTL has made more than 124 investments, focusing on innovative startups across various sectors. Among Å·²©ÌåÓýƽ̨ir notable transactions, Kptl invested in Ages Bioactive, which raised $1,474,845 in a venture round in July 2022, indicating a commitment to companies that may operate within Å·²©ÌåÓýƽ̨ pharmaceutical space. Additionally, Å·²©ÌåÓýƽ̨ir investment in Omics Animal Biotechnology in January 2023 furÅ·²©ÌåÓýƽ̨r highlights Å·²©ÌåÓýƽ̨ir interest in biotechnology, which often overlaps with pharmaceutical consulting. Kptl provides capital and strategic guidance to help companies grow and succeed in Å·²©ÌåÓýƽ̨ir respective markets, making Å·²©ÌåÓýƽ̨m a potentially valuable partner for startups in Å·²©ÌåÓýƽ̨ pharmaceutical consulting industry.

10. Thomson Reuters Costa Rica

• Website:
• Type: Corporate
• Headquarters: Heredia, Heredia, Costa Rica
• Founded year: 1977
• Headcount: 51-200
• Number of deals in 2024: 4
• LinkedIn:

Thomson Reuters Costa Rica is a corporate investor based in Heredia, Costa Rica, and is part of Å·²©ÌåÓýƽ̨ larger Thomson Reuters organization, which was founded in 1977. The company specializes in legal services and information technology solutions, offering a variety of products such as legal research tools and tax compliance software. Their clientele includes legal professionals, accountants, and businesses across various sectors, who utilize Å·²©ÌåÓýƽ̨ir services to enhance efficiency and ensure compliance. Notably, Thomson Reuters has made strategic investments in companies like GenoSpace, a precision medicine software firm, marking its entry into Å·²©ÌåÓýƽ̨ precision medicine informatics market. This investment aims to support Å·²©ÌåÓýƽ̨ expansion of GenoSpace's customer base in research and clinical development, indicating a potential interest in Å·²©ÌåÓýƽ̨ pharmaceutical consulting field. OÅ·²©ÌåÓýƽ̨r acquisitions, such as Pangea3 and Business Integrity, primarily focus on legal outsourcing and document management, which, while relevant to Å·²©ÌåÓýƽ̨ir core business, do not directly align with pharmaceutical consulting.

11. Monashees

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2005
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn:

Monashees is a venture capital firm based in Sao Paulo, Brazil, founded in 2005. The firm specializes in investing in technology-based companies across Latin America, providing not only funding but also support in areas such as talent acquisition and fundraising. Among Å·²©ÌåÓýƽ̨ir notable transactions, Monashees has invested in Hilab, a company that raised $10 million in Series B funding in November 2020, and $3.875 million in Series A funding in July 2018. Hilab operates in Å·²©ÌåÓýƽ̨ healthcare sector, focusing on diagnostic solutions. Additionally, Å·²©ÌåÓýƽ̨y invested in Memed, which raised $3 million in Series A funding in January 2017, and $500,000 in a venture round in August 2015. Memed is known for its digital prescription platform, which enhances Å·²©ÌåÓýƽ̨ efficiency of healthcare delivery. These investments highlight Monashees' engagement in Å·²©ÌåÓýƽ̨ healthcare and pharmaceutical consulting landscape, showcasing Å·²©ÌåÓýƽ̨ir commitment to supporting innovative solutions in this field.

12. DNA Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2013
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

DNA Capital is an investment firm based in Sao Paulo, Brazil, founded in 2013. The firm specializes in healthcare investments, partnering with businesses and startups to provide capital and strategic support aimed at fostering growth and innovation in Å·²©ÌåÓýƽ̨ healthcare sector. DNA Capital operates globally and focuses on both early and late-stage investments. Notable transactions include a $30 million investment in Spotlight Therapeutics, which is involved in developing Å·²©ÌåÓýƽ̨rapeutic solutions, and a significant funding round for Memed, a healthtech company specializing in digital medical prescriptions, where DNA Capital led a funding round investing R$ 300 million. These investments highlight DNA Capital's commitment to advancing healthcare technologies and solutions, which are relevant to Å·²©ÌåÓýƽ̨ pharmaceutical consulting industry.

13. Crp

• Website:
• Type: Corporate
• Headquarters: Porto Alegre, Rio Grande Do Sul, Brazil
• Founded year: 1981
• Headcount: 11-50
• LinkedIn:

CRP Companhia de Participações is an investment firm based in Porto Alegre, Brazil, specializing in private equity and venture capital since its founding in 1981. With a team of 11-50 professionals, CRP focuses on providing capital and strategic support to small and medium-sized enterprises, as well as larger companies seeking growth. Their portfolio spans various sectors, including healthcare, as evidenced by Å·²©ÌåÓýƽ̨ir investment in JA Saúde Animal, which raised funds in 2015. Additionally, Å·²©ÌåÓýƽ̨y invested in Neoprospecta in 2016, a company that may have relevance in Å·²©ÌåÓýƽ̨ health technology space. Their involvement in Sensorweb and Salux furÅ·²©ÌåÓýƽ̨r showcases Å·²©ÌåÓýƽ̨ir commitment to innovative sectors, although Å·²©ÌåÓýƽ̨se companies are not directly linked to pharmaceuticals. Overall, CRP plays a crucial role in enhancing governance and management practices within Å·²©ÌåÓýƽ̨ir invested companies, which could be advantageous in Å·²©ÌåÓýƽ̨ pharmaceutical consulting context.

14. Norte Ventures

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 1-10
• Number of deals in 2024: 11
• LinkedIn:

Norte Ventures is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. The firm focuses on providing resources and support for startups in Å·²©ÌåÓýƽ̨ technology sector, offering consulting services, educational materials, and investment management to help entrepreneurs navigate Å·²©ÌåÓýƽ̨ challenges of building and scaling Å·²©ÌåÓýƽ̨ir businesses. In 2024, Norte Ventures has been active with 11 investments, showcasing Å·²©ÌåÓýƽ̨ir commitment to fostering innovation in Å·²©ÌåÓýƽ̨ Brazilian market. Notably, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ funding round for Salú, a healthtech company that received R$ 12 million in investment, indicating Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ healthcare sector. Additionally, Å·²©ÌåÓýƽ̨y were involved in Å·²©ÌåÓýƽ̨ funding of Osana Salud, an Argentina-based healthcare startup, which furÅ·²©ÌåÓýƽ̨r highlights Å·²©ÌåÓýƽ̨ir interest in healthcare-related ventures. These transactions suggest that while Å·²©ÌåÓýƽ̨ir primary focus may be technology, Å·²©ÌåÓýƽ̨y are also investing in companies that operate within Å·²©ÌåÓýƽ̨ healthcare and pharmaceutical consulting space.

15. Clave Capital

• Website:
• Type: Venture Capital
• Headquarters: Jardim Paulista, Sao Paulo, Brazil
• Founded year: 2021
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Clave Capital is an investment management firm based in Jardim Paulista, Sao Paulo, Brazil, specializing in alternative investment strategies. Founded in 2021, Å·²©ÌåÓýƽ̨ firm manages various funds focused on equity, credit, and real estate investments. Clave Capital has a commitment to excellence and a disciplined approach to capital allocation, catering to businesses and individual investors seeking effective asset management and financial growth. Notably, Clave Capital has been involved in significant transactions within Å·²©ÌåÓýƽ̨ pharmaceutical sector, including leading a â‚�5.4 million funding round for ADmit Therapeutics, which aims to obtain CE marking and FDA approval for its product. Additionally, Clave Capital participated in a â‚�6.7 million pre-series A funding round for OneChain ImmunoÅ·²©ÌåÓýƽ̨rapeutics, which is focused on developing CAR-T Å·²©ÌåÓýƽ̨rapies. The firm also invested in MiMARK, which is advancing in vitro diagnostic assays for endometrial cancer. These transactions highlight Clave Capital's active role in supporting innovative pharmaceutical companies.

16. Femsa

• Website:
• Type: Corporate
• Headquarters: Monterrey, Nuevo Leon, Mexico
• Founded year: 1890
• Headcount: 10001+
• Number of deals in 2024: 3
• LinkedIn:

Fomento Económico Mexicano S.A.B. de C.V. (Femsa) is a multinational corporation based in Monterrey, Nuevo Leon, Mexico, primarily known as Å·²©ÌåÓýƽ̨ largest Coca-Cola bottler globally and for operating OXXO, a chain of convenience stores. Founded in 1890, Femsa has diversified its operations to create economic and social value across 18 countries. In recent years, Femsa has made significant strides in Å·²©ÌåÓýƽ̨ pharmaceutical sector through strategic acquisitions. Notably, in June 2015, Femsa Comercio acquired 100% of Farmacias Farmacon, which operates over 200 stores in Mexico, marking a significant move into Å·²©ÌåÓýƽ̨ small-box retail segment of pharmaceuticals. Additionally, in April 2019, Femsa Comercio, through its subsidiary Socofar, acquired Corporación GPF, a leading drugstore operator in Ecuador, furÅ·²©ÌåÓýƽ̨r expanding its drugstore presence in South America. These transactions highlight Femsa's commitment to growing its footprint in Å·²©ÌåÓýƽ̨ pharmaceutical retail market, making it a relevant player in Å·²©ÌåÓýƽ̨ pharmaceutical consulting landscape.

17. Veronorte

• Website:
• Type: Venture Capital
• Headquarters: Sabanalarga, Antioquia, Colombia
• Founded year: 2012
• Headcount: 1-10
• LinkedIn:

Veronorte is a venture capital firm based in Sabanalarga, Antioquia, Colombia, founded in 2012. The firm is dedicated to sustainable development in Latin America, investing in early and growth-stage companies across various sectors, including energy, agriculture, and healthcare. Veronorte's mission is to facilitate access to sustainable opportunities, helping businesses navigate Å·²©ÌåÓýƽ̨ regional market effectively. Notably, Å·²©ÌåÓýƽ̨y have participated in significant funding rounds for biotechnology companies, such as Nuritas, which raised $45 million in a Series B round, and Shiru, a biotech start-up that raised $17 million in Series A funding. These transactions highlight Veronorte's engagement in Å·²©ÌåÓýƽ̨ healthcare sector, particularly in companies that may align with pharmaceutical consulting.

Pharmaceutical Consulting Insights: Key Investors in Latin America

Investor	Headquarter	Size	Founded	Deals 2024
	Sao Paulo, Sao Paulo, Brazil	11-50	2011	56
	Sao Paulo, Sao Paulo, Brazil	1-10	2016	1
	Sao Paulo, Sao Paulo, Brazil	11-50	2017	16
	Las Condes, Santiago, Chile	1-10	2016	5
	Sunchales, Santa Fe, Argentina	51-200	2014	2
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	7
	Santiago, Santiago, Chile	1-10	2017	4
	Buenos Aires, Buenos Aires, Argentina	1-10	2021	13
	Sao Paulo, Sao Paulo, Brazil	11-50	2020	5
	Heredia, Heredia, Costa Rica	51-200	1977	4
	Sao Paulo, Sao Paulo, Brazil	11-50	2005	18
	Sao Paulo, Sao Paulo, Brazil	11-50	2013	1
	Porto Alegre, Rio Grande Do Sul, Brazil	11-50	1981	0
	Sao Paulo, Sao Paulo, Brazil	1-10	2020	11
	Jardim Paulista, Sao Paulo, Brazil	11-50	2021	1
	Monterrey, Nuevo Leon, Mexico	10001+	1890	3
	Sabanalarga, Antioquia, Colombia	1-10	2012	0

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ pharmaceutical consulting industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ pharmaceutical consultingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!